TORONTO, June 27, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its wholly owned subsidiary, MediPharm Labs Inc., has entered into purchase agreements to secure a substantial
[Read More ...]
from
https://www.newcannabisventures.com/medipharm-labs-secures-9000-kg-of-dried-cannabis-adding-substantial-private-label-cannabis-extract-production/
No comments:
Post a Comment